/
INTRODUCTION STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe.
18.56% operating margin is respectable but not wide. ROIC at 9.29%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 8.7%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$5.94B
▲ +8.7% YoY
Net Income (TTM)
$782M
▲ +27.3% YoY
Op. Margin
18.56%
▲ +2.7pp YoY
ROIC
9.29%
▲ +1.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$972M
▲ +25.0% YoY
Op. Cash Flow (TTM)
$1.34B
▲ +16.8% YoY
Net Debt
$1.65B
Cash & Equiv.
$440M
5Y CAGR: +13.8%
5Y CAGR: +16.6%
Continue Research